AI News about otcqb
Latest news and AI summaries about otcqb · 2 articles
About otcqb
Latest AI-curated news and analysis about otcqb, including breaking stories, expert analysis, and global coverage. Updated in real-time with AI-powered summaries to keep you informed.
Related: emmaus life sciences · sickle cell disease · biopharmaceutical · emma · rare disease treatment
Trending Topics
Emmaus Life Sciences Reports Annual Financial Results
Emmaus Life Sciences Posts 2025 Annual Results Emmaus Life Sciences, a biopharmaceutical company specializing in sickle cell disease treatment, released its 2025 financial results. The OTCQB-listed firm reported on its operational performance and financial condition for the year ending December 31, 2025. The announcement marks the company's latest update on its commercial-stage initiatives.
Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace · 2026.04.02
Micromem Technologies Inc. Provides Update on Liquid-Sensing Technology Development
Micromem's Liquid-Sensing Tech Hits Development Milestone Micromem Technologies Inc. announced progress on its liquid-sensing technology platform, advancing its commercial development efforts. The Toronto-based company, trading on Canadian and U.S. exchanges, is building capabilities for industrial and consumer applications. The update signals momentum in the company's product roadmap.
2026.03.31